SOUTH SAN FRANCISCO, CA, US - Patent application

Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

SOUTH SAN FRANCISCO, CA US

1. 20110047103 ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER 02-24-2011
2. 20110046066 INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds 02-24-2011
3. 20110044977 Subcutaneous anti-HER2 antibody formulations and uses thereof 02-24-2011
4. 20110039324 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS 02-17-2011
5. 20110034694 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 02-10-2011
6. 20110034487 CXCR3 ANTAGONISTS - Compounds, compositions and methods that are useful in the treatment of inflammatory and immune conditions and diseases are provided 02-10-2011
7. 20110028348 BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS 02-03-2011
8. 20110027275 INHIBITION OF TUMOR METASTASIS - generally to the inhibition of angiogenesis and tumor metastasis 02-03-2011
9. 20110021787 QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 01-27-2011
10. 20110021597 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: STR00001 where R 01-27-2011
11. 20110021585 DUAL-ACTING ANTIHYPERTENSIVE AGENTS - compounds having the formula: STR00001 wherein: Ar, r, R 01-27-2011
12. 20110021556 PYRROLIDINYL DERIVATIVES AND USES THEREOF 01-27-2011
13. 20110021527 DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS 01-27-2011
14. 20110021496 THIENOPYRIMIDINE DERIVATIVES AS P13K INHIBITORS 01-27-2011
15. 20110020322 CRYSTALLIZATION OF ANTI-CD20 ANTIBODIES - generally to crystalline forms of anti-CD20 antibodies and purification of anti-CD20 antibodies involving 01-27-2011
16. 20110020300 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES 01-27-2011
17. 20110020231 QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 01-27-2011
18. 20110015163 CRYSTALLINE FREEBASE FORMS OF A BIPHENYL COMPOUND 01-20-2011
19. 20110015152 DIARYLMETHYL AND RELATED COMPOUNDS - This invention provides compounds of formula I: STR00001 wherein R 01-20-2011
20. 20110014194 METHODS FOR INHIBITING ANGIOGENESIS USING EGFL8 ANTAGONISTS 01-20-2011
21. 20110009465 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: STR00001 where R 01-13-2011
22. 20110009409 DUAL-ACTING PYRAZOLE ANTIHYPERTENSIVE AGENTS 01-13-2011
23. 20100331375 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 12-30-2010
24. 20100331305 OXO-HETEROCYCLE FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE 12-30-2010
25. 20100331251 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 12-30-2010
26. 20100330096 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 12-30-2010
27. 20100330082 NLRR-1 ANTAGONISTS AND USES THEREOF - NLRR-1 antagonists and methods of their use in treating cancer and other disorders are provided 12-30-2010
28. 20100330032 HETEROCYCLIC ANTIVIRAL COMPOUNDS - Compounds having the formula I wherein R 12-30-2010
29. 20100324070 INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS 12-23-2010
30. 20100324069 OXAZOLONE AND PYRROLIDINONE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS 12-23-2010
31. 20100322935 Tri- or Tetraspecific Antibodies - , their manufacture and use 12-23-2010
32. 20100317643 JANUS KINASE INHIBITOR COMPOUNDS AND METHODS 12-16-2010
33. 20100316652 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 12-16-2010
34. 20100316639 BIOMARKERS FOR IGF-1R INHIBITOR THERAPY - The invention concerns the identification and validation of certain biomarkers for selecting patients for 12-16-2010
35. 20100310581 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) 12-09-2010
36. 20100305096 BICYCLIC PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE 12-02-2010
37. 20100305084 BICYCLIC INDOLE-PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE 12-02-2010
38. 20100304982 SCAFFOLDED NUCLEIC ACID POLYMER PARTICLES AND METHODS OF MAKING AND USING 12-02-2010
39. 20100303810 METHOD FOR TREATING LUPUS - method of treating lupus in a subject eligible for treatment is provided involving administering an effective amount of an 12-02-2010
40. 20100300895 APPARATUS AND METHODS FOR PERFORMING ELECTROCHEMICAL REACTIONS 12-02-2010
41. 20100300559 FLUIDICS SYSTEM FOR SEQUENTIAL DELIVERY OF REAGENTS 12-02-2010
42. 20100298341 Glycine Transporter-1 Inhibitors - compounds that are glycine transporter 1 inhibitors and are therefore useful for the treatment of diseases treatable 11-25-2010
43. 20100292468 PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS 11-18-2010
44. 20100292312 ANTI-DLL4 ANTIBODIES AND METHODS USING SAME 11-18-2010
45. 20100292223 INDAZOLE-CARBOXAMIDE COMPOUNDS - The invention provides novel indazole-carboxamide 5-HT 11-18-2010
46. 20100291114 Crystal structures and methods using same 11-18-2010
47. 20100291072 ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES 11-18-2010
48. 20100285519 QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 11-11-2010
49. 20100285010 TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY 11-11-2010
50. 20100285009 HUMANIZED ANTI-EGFL7 ANTIBODIES AND METHODS USING SAME 11-11-2010
51. 20100280063 8-ANILINOIMIDAZOPYRIDINES AND THEIR USE AS ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS 11-04-2010
52. 20100279298 Methods and Compositions For Detecting Autoimmune Disorders 11-04-2010
53. 20100278842 ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME 11-04-2010
54. 20100273755 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY 10-28-2010
55. 20100273257 Apo-2DcR - Novel polypeptides, designated Apo-2DcR, which are capable of binding Apo-2 ligand are provided 10-28-2010
56. 20100272738 ANTI-OX40L ANTIBODIES AND METHODS USING SAME 10-28-2010
57. 20100269184 Apo-2DcR - Novel polypeptides, designated Apo-2DcR, which are capable of binding Apo-2 ligand are provided 10-21-2010
58. 20100267788 DUAL-ACTING ANTIHYPERTENSIVE AGENTS - The invention is directed to compounds of formula I: STR00001 wherein Ar, r, R 10-21-2010
59. 20100267743 3-(PHENOXYPYRROLIDIN-3-YL-METHYL)HETEROARYL, 3-(PHENYLPYRROLIDIN-3-YLMETHOXY)HETEROARYL, AND 3-(HETEROARYLPYRROLIDIN-3-YLMETHOXY)HETEROARYL COMPOUNDS 10-21-2010
60. 20100267050 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN 10-21-2010
61. 20100267033 Methods and Compositions For Detecting Autoimmune Disorders 10-21-2010
62. 20100266698 USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS 10-21-2010
63. 20100266593 WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS 10-21-2010
64. 20100266589 ADJUVANT CANCER THERAPY - Disclosed herein are methods and compostions comprising anti-VEGF antibodies for use in adjuvant cancer therapy 10-21-2010
65. 20100261888 Recombinant Production of Heparin Binding Proteins 10-14-2010
66. 20100261752 5-HT4 RECEPTOR AGONIST COMPOUNDS FOR TREATMENT OF COGNITIVE DISORDERS 10-14-2010
67. 20100261716 INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 10-14-2010
68. 20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF 10-14-2010
69. 20100257778 PRODUCTION OF FATTY ACID DERIVATIVES - Methods and compositions for producing fatty acid derivatives, for example, fatty esters, are described 10-14-2010
70. 20100257777 PRODUCTION OF COMMERCIAL BIODIESEL FROM GENETICALLY MODIFIED MICROORGANISMS 10-14-2010
71. 20100256185 CRYSTALLINE FORMS OF A BIPHENYL COMPOUND 10-07-2010
72. 20100256115 INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds 10-07-2010
73. 20100255515 ELISA FOR VEGF - The vascular endothelial growth factor activity in a patient's bloodstream or other biological sample can serve as a diagnostic and 10-07-2010
74. 20100255508 USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS 10-07-2010
75. 20100255010 ANTI-HER ANTIBODIES - The invention provides anti-HER antibodies including multispecific anti-HER antibodies compositions comprising and methods of 10-07-2010
76. 20100251601 ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES 10-07-2010
77. 20100249421 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 09-30-2010
78. 20100249186 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 09-30-2010
79. 20100247531 ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME 09-30-2010
80. 20100247430 Methods and Compositions for Modulating T Cells 09-30-2010
81. 20100242345 PRODUCTION OF FATTY ACIDS & DERIVATIVES THEREOF 09-30-2010
82. 20100240889 Urea Derivatives Methods For Their Manufacture And Uses Thereof 09-23-2010
83. 20100239567 Antibody Formulation - formulation comprising a therapeutically effective amount of an antibody optionally not subjected to prior lyophilization 09-23-2010
84. 20100235934 HYDROCARBON-PRODUCING GENES AND METHODS OF THEIR USE 09-16-2010
85. 20100233164 COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES 09-16-2010
86. 20100233153 NOVEL GENE DISRUPTIONS, COMPOSITIONS AND THE METHODS RELATING THERETO 09-16-2010
87. 20100233121 METHOD FOR TREATING MULTIPLE SCLEROSIS - Methods for treating multiple sclerosis with a CD20 antibody using special dosing regimens and protocols are 09-16-2010
88. 20100226925 Homogeneous Antibody Populations - The present invention is generally directed to methods of producing an increase in the enrichment and/or recovery of 09-09-2010
89. 20100226880 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 09-09-2010
90. 20100221262 ANTI-UNC5B ANTIBODIES AND METHODS OF USE 09-02-2010
91. 20100221176 METHODS AND COMPOSITIONS FOR PROTEIN LABELLING 09-02-2010
92. 20100216768 N-SUBSTITUTED AZAINDOLES AND METHODS OF USE 08-26-2010
93. 20100216663 NOVEL PROTEINS WITH TARGETED BINDING - Methods for identifying discrete monomer domains and immuno-domains with a desired property are provided 08-26-2010
94. 20100216115 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS 08-26-2010
95. 20100210826 HGF BETA CHAIN VARIANTS - The invention provides HGF/Met modulators comprising HGF having mutations in regions that affect HGF function 08-19-2010
96. 20100209956 METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION 08-19-2010
97. 20100204240 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus 08-12-2010
98. 20100204052 Protein scaffolds and uses thereof - thrombospondin thyroglobulin and trfoil/PD monomer domains and multimers comprising the monomer domains are 08-12-2010
99. 20100203056 ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION 08-12-2010
100. 20100203044 DR6 ANTAGONISTS AND USES THEREOF IN TREATING NEUROLOGICAL DISORDERS 08-12-2010
101. 20100203041 ANTIBODIES TO EGFL7 AND METHODS FOR THEIR USE 08-12-2010
102. 20100199548 SYSTEMS AND METHODS FOR THE PRODUCTION OF FATTY ESTERS 08-12-2010
103. 20100197922 AZABICYCLOALKANE COMPOUNDS - This invention provides compounds of formula I: STR00001 wherein R 08-05-2010
104. 20100197728 CRYSTALLINE FORM OF A QUINOLINONE-CARBOXAMIDE COMPOUND 08-05-2010
105. 20100197667 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 08-05-2010
106. 20100197569 CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS 08-05-2010
107. 20100190769 THIAZOLOPYRIMIDINES AND THEIR USE AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3 KINASE 07-29-2010
108. 20100189660 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEIN 07-29-2010
109. 20100172895 Human CGRP Receptor Binding Proteins - Antigen binding proteins that bind to human CGRP receptor are provided 07-08-2010
110. 20100170826 PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT HYDROCARBONS FROM RENEWABLE RESOURCES 07-08-2010
111. 20100166749 Polypeptide variants with altered effector function 07-01-2010
112. 20100162415 TRANSGENIC MICE EXPRESSING HUMANIZED VEGF 06-24-2010
113. 20100160211 GLYCOPEPTIDE PHOSPHONATE DERIVATIVES - Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more 06-24-2010
114. 20100158914 KLOTHO BETA - The invention concerns uses of anti-KL 06-24-2010
115. 20100158856 Assays and methods using biomarkers - Methods and assays examining expression of one or more biomarkers in a mammalian tissue or cell sample are 06-24-2010
116. 20100154293 METHODS AND COMPOSITIONS RELATED TO THIOESTERASE ENZYMES 06-24-2010
117. 20100152199 HETEROARYLALKYL-8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 06-17-2010
118. 20100150928 METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES 06-17-2010
119. 20100145027 Compositions and Methods for the Diagnosis and Treatment of Tumor 06-10-2010
120. 20100144881 CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND 06-10-2010
121. 20100144732 PYRIMIDINE KINASE INHIBITORS - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 06-10-2010
122. 20100143351 Anti-Angiogenesis Therapy for the Treatment of Breast Cancer 06-10-2010
123. 20100137603 DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 06-03-2010
124. 20100137394 PYRAZOLE INHIBITORS OF WNT SIGNALING - The invention provides inhibitors of Wnt signaling that are useful as a therapeutic agents for treating 06-03-2010
125. 20100137325 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 06-03-2010
126. 20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method 06-03-2010
127. 20100136580 DISHEVELED PDZ MODULATORS - The invention provides modulators of Dvl PDZ-ligand interaction, and methods of identifying and using these modulators 06-03-2010
128. 20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies 06-03-2010
129. 20100130539 IMIDAZOPYRIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where 05-27-2010
130. 20100129375 METHODS FOR INHIBITING OCULAR ANGIOGENESIS 05-27-2010
131. 20100129356 COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT 05-27-2010
132. 20100125150 CRYSTALLINE FORM OF A BETA2 ADRENERGIC RECEPTOR AGONIST 05-20-2010
133. 20100125141 PROCESS FOR PREPARING 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS 05-20-2010
134. 20100125093 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND 05-20-2010
135. 20100125092 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS 05-20-2010
136. 20100125079 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 05-20-2010
137. 20100119523 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 05-13-2010
138. 20100113350 METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN 05-06-2010
139. 20100112661 ONCOKINASE FUSION POLYPEPTIDES ASSOCIATED WITH HYPERPROLIFERATIVE AND RELATED DISORDERS, NUCLEIC ACIDS ENCODING THE SAME AND METHODS FOR DETECTING AND IDENTIFYING THE SAME 05-06-2010
140. 20100111971 ANTI-NOTCH3 AGONIST ANTIBODIES AND THEIR USE IN THE TREATMENT OF NOTCH3-RELATED DISEASES 05-06-2010
141. 20100111963 METHOD FOR TREATING AGE-RELATED MACULAR DEGENERATION 05-06-2010
142. 20100111856 ZIRCONIUM-RADIOLABELED, CYSTEINE ENGINEERED ANTIBODY CONJUGATES 05-06-2010
143. 20100099134 METHODS FOR DETECTING SULFHYDRYL-CONTAINING COMPOUNDS IN A BIOLOGICAL TEST SAMPLE 04-22-2010
144. 20100099101 METHODS FOR TREATING, DIAGNOSING, AND MONITORING LUPUS 04-22-2010
145. 20100098730 IMMUNOGLOBULIN VARIANTS AND USES THEREOF 04-22-2010
146. 20100098624 METHOD FOR USING CDO ANTAGONISTS TO MODULATE HEDGEHOG SIGNALING 04-22-2010
147. 20100093753 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 04-15-2010
148. 20100093628 METHODS OF TREATMENT USING WISP POLYPEPTIDES 04-15-2010
149. 20100092965 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 04-15-2010
150. 20100092492 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 04-15-2010
151. 20100087624 Methods for making recombinant proteins using apoptosis inhibitors 04-08-2010
152. 20100087440 Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use 04-08-2010
153. 20100087410 ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS 04-08-2010
154. 20100086544 COMPOSITIONS AND METHODS FOR TREATING A NEOPLASM 04-08-2010
155. 20100086517 Enhancement of B cell proliferation by IL-15 04-08-2010
156. 20100081697 CRYSTALLINE FORM OF AN ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID 04-01-2010
157. 20100081609 PHARMACEUTICAL COMPOSITIONS CONTAINING A GLYCOPEPTIDE ANTIBIOTIC AND A CYCLODEXTRIN 04-01-2010
158. 20100080810 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 04-01-2010
159. 20100080808 ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE 04-01-2010
160. 20100080793 DcR3 polypeptide, A TNFR homolog - TNFR homolog, identified as DcR3, is provided 04-01-2010
161. 20100077495 COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS 03-25-2010
162. 20100075947 Methods of Using PI3K and MEK Modulators 03-25-2010
163. 20100069357 PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE 03-18-2010
164. 20100063096 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-11-2010
165. 20100061996 METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR 03-11-2010
166. 20100056541 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-04-2010
167. 20100056517 ARYLSULFONAMIDE COMPOUNDS - The invention relates generally to small molecules that mimic the biological activity of certain peptides and proteins 03-04-2010
168. 20100055099 Diagnostics and Treatments for VEGF-Independent Tumors 03-04-2010
169. 20100055095 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 03-04-2010
170. 20100048622 CRYSTALLINE FORMS OF A BIPHENYL COMPOUND 02-25-2010
171. 20100047236 ANTIBODY VARIANTS - of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and 02-25-2010
172. 20100041701 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 02-18-2010
173. 20100040634 METHODS AND COMPOSITIONS FOR MODULATING HGF/MET 02-18-2010
174. 20100035921 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 02-11-2010
175. 20100035236 ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES 02-11-2010
176. 20100034837 ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS 02-11-2010
177. 20100034836 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND ALLEVIATION OF TUMOR 02-11-2010
178. 20100034821 GENETIC VARIATIONS ASSOCIATED WITH TUMORS 02-11-2010
179. 20100029946 CRYSTALLINE FORM OF A BENZIMIDAZOLE-CARBOXAMIDE MEDICINAL COMPOUND 02-04-2010
180. 20100029611 S1P1 receptor agonists and use thereof - compounds of Formula : STR00001 that are have activity as S1P receptor modulating agents 02-04-2010
181. 20100029491 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE FOR TUMOR TREATMENT 02-04-2010
182. 20100028365 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 02-04-2010
183. 20100028337 METHODS AND COMPOSITIONS FOR MODULATING HYPERSTABILIZED C-MET 02-04-2010
184. 20100022616 3-(PHENOXYPHENYLMETHYL)PYRROLIDINE COMPOUNDS 01-28-2010
185. 20100022599 DUAL-ACTING ANTIHYPERTENSIVE AGENTS - In one aspect, the invention relates to compounds having the formula: STR00001 wherein: Ar, r, Z, X, R 01-28-2010
186. 20100021474 METHODS AND COMPOSITIONS FOR TARGETING HEPSIN 01-28-2010
187. 20100021460 Methods of Treating Autoimmune Diseases Using CD4 Antibodies 01-28-2010
188. 20100021395 CRYSTALLINE FORMS OF A BIPHENYL COMPOUND 01-28-2010
189. 20100016241 METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION 01-21-2010
190. 20100015157 ANTIBODY FORMULATIONS - The present application describes antibody formulations including monoclonal antibodies formulated in histidine-acetate buffer 01-21-2010
191. 20100015135 ANTI-EPHB4 ANTIBODIES AND METHODS USING SAME 01-21-2010
192. 20100015055 PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT 01-21-2010
193. 20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same 01-14-2010
194. 20100008910 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 01-14-2010
195. 20100004269 5-ANILINOIMIDAZOPYRIDINES AND METHODS OF USE 01-07-2010
196. 20100003766 CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES 01-07-2010
197. 20100003239 ANTI-HEDGEHOG ANTIBODIES - their use in the detection of hedgehog expression in tissue 01-07-2010
198. 20090325962 TYROSINE DERIVATIVE - The compounds of the invention are inhibitors of alpha4 containing integrin-mediated binding to ligands such as VCAM-1 and MAdCAM 12-31-2009
199. 20090324595 CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS 12-31-2009
200. 20090318436 Fused heterocyclic derivatives and methods of use 12-24-2009
201. 20090318411 PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE 12-24-2009
202. 20090318409 PYRROLIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the 12-24-2009
203. 20090317384 Methods of using death receptor ligands and cd20 antibodies 12-24-2009
204. 20090312312 Heterobicyclic Metalloprotease Inhibitors 12-17-2009
205. 20090311255 PREVENTING AUTOIMMUNE DISEASE - The present application describes a method of preventing an autoimmune disease in an asymptomatic human subject at risk 12-17-2009
206. 20090311250 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER 12-17-2009
207. 20090306134 Muscarinic receptor antagonists - Disclosed are multibinding compounds which are muscarinic receptor antagonists 12-10-2009
208. 20090305962 IL-6 binding proteins - Polypeptides comprising monomer domains that bind to IL-6, or portions thereof, are provided 12-10-2009
209. 20090304701 ANTIBODIES BINDING IL-1 RELATED POLYPEPTIDES 12-10-2009
210. 20090298830 4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use 12-03-2009
211. 20090297531 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 12-03-2009
212. 20090297512 COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT 12-03-2009
213. 20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-26-2009
214. 20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-19-2009
215. 20090286258 ANALYSIS OF ANTIBODY DRUG CONJUGATES BY BEAD-BASED AFFINITY CAPTURE AND MASS SPECTROMETRY 11-19-2009
216. 20090285837 HER2 ANTIBODY COMPOSITION - composition comprising a main species HER2 antibody that binds to domain II of HER2 and an amino acid sequence variant 11-19-2009
217. 20090285830 ANTIBODIES TO LYMPHOTOXIN-ALPHA - The invention provides various antibodies that bind to lymphotoxin 11-19-2009
218. 20090275659 Phenyl acetic acid derivatives as inflammation modulators 11-05-2009
219. 20090270595 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
220. 20090270473 DUAL-ACTING ANTIHYPERTENSIVE AGENTS - compounds having the formula: STR00001 wherein: Q W Y 10-29-2009
221. 20090269811 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
222. 20090269351 METHOD OF DIAGNOSING AND TREATING GLIOMA 10-29-2009
223. 20090269339 RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY 10-29-2009
224. 20090269338 HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF 10-29-2009
225. 20090264370 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 10-22-2009
226. 20090258025 TREATMENTS AND DIAGNOSTICS FOR CANCER, INFLAMMATORY DISORDERS AND AUTOIMMUNE DISORDERS 10-15-2009
227. 20090258013 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 10-15-2009
228. 20090247627 AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 10-01-2009
229. 20090246173 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-01-2009
230. 20090239904 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 09-24-2009
231. 20090239236 GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY 09-24-2009
232. 20090226465 MACROCYCLIC DEPSIPEPTIDE ANTIBODY-DRUG CONJUGATES AND METHODS 09-10-2009
233. 20090221638 CRYSTALLINE FORM OF A BIPHENYL COMPOUND - crystalline 1,2-ethanedisulfonic acid salt of biphenyl-2-ylcarbamic acid 1-[2--2-hydroxy-2 09-03-2009
234. 20090221630 IAP INHIBITORS - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have 09-03-2009
235. 20090221470 USE OF AN ECHINOCANDIN ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT 09-03-2009
236. 20090220504 COMBINATORIAL THERAPY - the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular 09-03-2009
237. 20090215982 GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 08-27-2009
238. 20090215803 Pyrimidinones as Casein Kinase II (CK2) Modulators 08-27-2009
239. 20090215674 USE OF A POLYENE MACROLIDE ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT 08-27-2009
240. 20090215673 PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES 08-27-2009
241. 20090214564 ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME 08-27-2009
242. 20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same 08-20-2009
243. 20090209582 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists 08-20-2009
244. 20090208500 Method of producing antibodies with improved function 08-20-2009
245. 20090204489 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 08-13-2009
246. 20090202546 COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF 08-13-2009
247. 20090202536 ANTIBODY-DRUG CONJUGATES AND METHODS - antibody-drug conjugate compounds of Formula I: Ab 08-13-2009
248. 20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto 08-06-2009
249. 20090192289 OMI PDZ MODULATORS - The invention provides modulators of Omi PDZ-ligand interaction, and methods of identifying and using these modulators 07-30-2009
250. 20090191215 Treatment with anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 07-30-2009
251. 20090191209 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN 07-30-2009
252. 20090191184 DcR3 polypeptide, A TNFR homolog - TNFR homolog, identified as DcR3, is provided 07-30-2009
253. 20090186812 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 07-23-2009
254. 20090186409 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
255. 20090186363 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
256. 20090186018 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS 07-23-2009
257. 20090181024 NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-16-2009
258. 20090176833 DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 07-09-2009
259. 20090176822 PYRROLIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the 07-09-2009
260. 20090176774 Compounds and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases 07-09-2009
261. 20090176767 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 07-09-2009
262. 20090175865 CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES 07-09-2009
263. 20090175855 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-09-2009
264. 20090175854 Methods of using death receptor ligands and CD20 antibodies 07-09-2009
265. 20090170870 AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 07-02-2009
266. 20090169569 APO-2L receptor agonist and CPT-11 synergism 07-02-2009
267. 20090169556 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 07-02-2009
268. 20090169550 THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS 07-02-2009
269. 20090163471 Tropane compounds - compound according to Formula I or II: STR00001 wherein R 06-25-2009
270. 20090163419 Human growth hormone aqueous formulation 06-25-2009
271. 20090162364 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 06-25-2009
272. 20090155807 C-MET MUTATIONS IN LUNG CANCER - The invention provides methods and compositions useful for detecting mutations in c-met in lung cancer cells 06-18-2009
273. 20090155259 EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS 06-18-2009
274. 20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors 06-18-2009
275. 20090149535 3-CARBOXYPROPYL-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 06-11-2009
276. 20090149521 DUAL-ACTING BENZOIMIDAZOLE ANTIHYPERTENSIVE AGENTS 06-11-2009
277. 20090149465 AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 06-11-2009
278. 20090149454 Benzomorpholine derivatives and methods of use 06-11-2009
279. 20090148921 Compositions and methods for enhancing apoptosis 06-11-2009
280. 20090148457 HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF 06-11-2009
281. 20090148448 METHODS AND COMPOSITIONS FOR MODULATING AND DETECTING WISP ACTIVITY 06-11-2009
282. 20090148435 ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY 06-11-2009
283. 20090143386 Human adam-10 inhibitors - compounds useful for inhibiting the ADAM-10 protein 06-04-2009
284. 20090142786 SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 06-04-2009
285. 20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto 06-04-2009
286. 20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors 06-04-2009
287. 20090137476 Apo-2 ligand variants and uses thereof - The disclosure provides Apo-2 ligand variant polypeptides 05-28-2009
288. 20090137460 Cross-linked glycopeptide-cephalosporin antibiotics 05-28-2009
289. 20090136997 PRO1550 POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 05-28-2009
290. 20090136492 THERAPY OF OCULAR DISORDERS - The present application describes therapy of ocular disorders using antagonists, such as antibodies, that bind to CD2 05-28-2009
291. 20090131407 TETRACYCLIC KINASE INHIBITORS - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 05-21-2009
292. 20090124612 Fused heterocyclic derivatives and methods of use 05-14-2009
293. 20090124609 Fused heterocyclic derivatives and methods of use 05-14-2009
294. 20090123930 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS 05-14-2009
295. 20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists 04-30-2009
296. 20090111737 Novel antibacterial agents - This invention relates to novel multibinding compounds that are antibacterial agents 04-30-2009
297. 20090099173 Pyridopyridazine compounds, compositions and methods of use 04-16-2009
298. 20090098112 NOVEL ANTIBODIES - the use of VEGF antagonists and a novel anti 04-16-2009
299. 20090093417 Dual-acting antihypertensive agents - compounds having the formula: STR00001 wherein: Ar, r, R 04-09-2009
300. 20090088453 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 04-02-2009
301. 20090087881 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same 04-02-2009
302. 20090087428 ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR 04-02-2009
303. 20090087426 Methods for Treatment of Allergic Asthma 04-02-2009
304. 20090083866 TRANSGENIC ROSA26-LUCIFERASE MICE FOR BIOLUMINESCENT IMAGING 03-26-2009
305. 20090082397 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-26-2009
306. 20090081232 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 03-26-2009
307. 20090081229 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 03-26-2009
308. 20090081223 FIXED DOSING OF HER ANTIBODIES - The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab 03-26-2009
309. 20090076026 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-19-2009
310. 20090075317 METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION 03-19-2009
311. 20090069534 Hydrochloride salts of a glycopeptide phosphonate derivative 03-12-2009
312. 20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists 03-12-2009
313. 20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin 03-12-2009
314. 20090068110 ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR 03-12-2009
315. 20090062335 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists 03-05-2009
316. 20090062334 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists 03-05-2009
317. 20090062333 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists 03-05-2009
318. 20090062332 Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists 03-05-2009
319. 20090062274 Pyridopyrimidinone inhibitors of pi3kalpha 03-05-2009
320. 20090054631 COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKIN'S LYMPHOMA 02-26-2009
321. 20090054624 PRO1190 POLYPEPTIDES - novel polypeptides having homology to CDO protein and to nucleic acid molecules encoding those polypeptides 02-26-2009
322. 20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor 02-26-2009
323. 20090054460 Piperazine derivatives and methods of use 02-26-2009
324. 20090053230 ANTI-OX40L ANTIBODIES AND METHODS USING SAME 02-26-2009
325. 20090053216 Treatment with Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 02-26-2009
326. 20090048313 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 02-19-2009
327. 20090048299 Biphenyl compounds useful as muscarinic receptor antagonists 02-19-2009
328. 20090048259 Phthalazine compounds, compositions and methods of use 02-19-2009
329. 20090047291 MODULATORS OF HEPATOCYTE GROWTH FACTOR ACTIVATOR 02-19-2009
330. 20090041788 Apo-2L receptor agonist and CPT-11 synergism 02-12-2009
331. 20090041749 Compositions and methods for the diagnosis and treatment of tumor 02-12-2009
332. 20090041742 HUMAN DNASE II - This invention relates to a novel human deoxyribonuclease, referred to as human DNase II 02-12-2009
333. 20090036483 QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 02-05-2009
334. 20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use 01-29-2009
335. 20090023934 Process for preparing an intermediate to opioid receptor antagonists 01-22-2009
336. 20090023777 Substituted 4-amino-benzylpiperidine compounds 01-22-2009
337. 20090023602 BINDING POLYPEPTIDES WITH RESTRICTED DIVERSITY SEQUENCES 01-22-2009
338. 20090023228 Dual-acting Imidazole antihypertensive agents 01-22-2009
339. 20090022713 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 01-22-2009
340. 20090018165 Biphenyl compounds useful as muscarinic receptor antagonists 01-15-2009
341. 20090018135 Methods of treating bowel disorders - methods for treating or preventing bowel disorders using calcimimetics 01-15-2009
342. 20090017559 Methods for diagnosing renal disorders - methods for diagnosing the presence and progress of pathologies characterized by an accumulation of the 01-15-2009
343. 20090017043 Connective tissues growth factor antibodies 01-15-2009
344. 20090012003 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 01-08-2009
345. 20090010925 ANTIBODY VARIANTS - of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and 01-08-2009
346. 20090010924 Apoptotic Anti-IgE Antibodies - The present application relates to apoptotic anti-IgE antibodies nucleic acid encoding the same 01-08-2009
347. 20090010883 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
348. 20090010881 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
349. 20090004204 Assays and methods using biomarkers - Methods and assays examining expression of one or more biomarkers in a mammalian tissue or cell sample are 01-01-2009
350. 20090004189 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 01-01-2009
351. 20080318989 Pyrimidine Kinase Inhibitors - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 12-25-2008
352. 20080318951 Dual-acting benzoimidazole antihypertensive agents 12-25-2008
353. 20080318800 METHODS AND COMPOSITIONS FOR DETECTING AUTOIMMUNE DISORDERS 12-25-2008
354. 20080317758 Polypeptide variants with altered effector function 12-25-2008
355. 20080317753 SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR 12-25-2008
356. 20080312407 Glycopeptide phosphonate derivatives - Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more 12-18-2008
357. 20080312232 Substituted amide derivatives and methods of use 12-18-2008
358. 20080311134 CYSTEINE ENGINEERED ANTI-MUC16 ANTIBODIES AND ANTIBODY DRUG CONJUGATES 12-18-2008
359. 20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto 12-18-2008
360. 20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same 12-11-2008
361. 20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto 12-11-2008
362. 20080299136 WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS 12-04-2008
363. 20080299119 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 12-04-2008
364. 20080299117 Treatment Method - The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg 12-04-2008
365. 20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof 12-04-2008
366. 20080299115 Antibody Variants with Faster Antigen Association Rates 12-04-2008
367. 20080293121 HUMAN DNASE I HYPERACTIVE VARIANTS - amino acid sequence variants of human DNase I that have increased DNA-hydrolytic activity 11-27-2008
368. 20080292631 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
369. 20080292630 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
370. 20080287486 Prokinetic agent for bowel preparation - The invention provides methods of bowel preparation before a diagnostic surgical or therapeutic procedure 11-20-2008
371. 20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity 11-20-2008
372. 20080281076 IL-6 binding proteins - Polypeptides comprising monomer domains that bind to IL-6, or portions thereof, are provided 11-13-2008
373. 20080280917 Nitrogen-Containing heterocyclyl ketones and methods of use 11-13-2008
374. 20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods 11-13-2008
375. 20080279860 Treatment With Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-13-2008
376. 20080274993 Methods and compositions for modulating vascular integrity 11-06-2008
377. 20080274506 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
378. 20080274108 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
379. 20080274105 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
380. 20080269344 Beta2-Adrenergic Receptor Agonists - Disclosed are multibinding compounds which are 10-30-2008
381. 20080269305 Dual-acting antihypertensive agents - The invention is directed to compounds having the formula: wherein: Ar, r, Y, Z, Q, W, X, and R 10-30-2008
382. 20080269190 Quaternary ammonium compounds useful as muscarinic receptor antagonists 10-30-2008
383. 20080267968 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-30-2008
384. 20080255187 5-HT4 RECEPTOR AGONIST COMPOUNDS - The invention provides novel quinolinone-carboxamide 5-HT 10-16-2008
385. 20080255181 Methods for treating podocyte-related disorders 10-16-2008
386. 20080254487 Connective Tissue Growth Factor Signaling 10-16-2008
387. 20080254024 ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME 10-16-2008
388. 20080249106 Novel B1 bradykinin receptor antagonists 10-09-2008
389. 20080248049 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
390. 20080248037 Dr5 Antibodies and Uses Thereof - The application provides antibodies which specifically bind to DR5 receptor 10-09-2008
391. 20080248036 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
392. 20080247951 ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies and compositions comprising the antibodies and methods of using 10-09-2008
393. 20080242709 2-AMIDO-4-ISOXAZOLYL THIAZOLE COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 10-02-2008
394. 20080242655 AZA-INDOLYL COMPOUNDS AND METHODS OF USE 10-02-2008
395. 20080241898 Application of Glucose Transport Mutants For Production Of Aromatic Pathway Compounds 10-02-2008
396. 20080241159 METHODS AND COMPOSITIONS FOR SELECTIVE MODULATION OF VASCULARIZATION 10-02-2008
397. 20080241148 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-02-2008
398. 20080241146 Apo-2 ligand-anti-Her-2 antibody synergism 10-02-2008
399. 20080241143 Inhibition of leukocyte adhesion - This invention relates to the inhibition of intercellular adhesion mediated by L-selectin by administering a newly 10-02-2008
400. 20080234268 Bis-aryl amide derivatives and methods of use 09-25-2008
401. 20080233646 Human DR4 antibodies and uses thereof - Human Death Receptor 4 antibodies are provided 09-25-2008
402. 20080227963 Process for preparing glycopeptide phosphonate derivatives 09-18-2008
403. 20080227119 ELISA for VEGF - The vascular endothelial growth factor activity in a patient's bloodstream or other biological sample can serve as a diagnostic and 09-18-2008
404. 20080226629 ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed 09-18-2008
405. 20080226621 ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES 09-18-2008
406. 20080221101 Calcium receptor modulating agents - generally to compounds represented in Formula I pharmaceutical compositions comprising them and methods of treating 09-11-2008
407. 20080221014 Method of Diagnosing and Treating Glioma 09-11-2008
408. 20080220471 Vectors and Methods Using Same - vectors and to methods of using same 09-11-2008
409. 20080214544 Substituted heterocycles and methods of use 09-04-2008
410. 20080213837 Apo-3 ligand polypeptide - tumor necrosis factor and lymphotoxin homolog having apoptotic activity, identified as Apo-3 Ligand, is provided 09-04-2008
411. 20080213280 THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPONSE TO A TNF-ALPHA INHIBITOR 09-04-2008
412. 20080213272 VEGF-RELATED PROTEIN - human VEGF-related protein has been identified and isolated that binds to and stimulates the phosphorylation of 09-04-2008
413. 20080213268 NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed 09-04-2008
414. 20080207736 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists 08-28-2008
415. 20080207676 Crystalline forms of an 8-Azabicyclo(3.2.1)octane compound 08-28-2008
416. 20080206256 Treatments for cancer - methods for reducing tumor survival, expansion, and metastasis 08-28-2008
417. 20080206243 Methods for Treating Kidney Disorders - Provided are methods of treating kidney disorders in a subject by administering an effective amount of VEGFR 08-28-2008
418. 20080200464 Substituted heterocycles and methods of use 08-21-2008
419. 20080200375 Angiogenesis using hepatocyte growth factor 08-21-2008
420. 20080199464 Combination Therapy with Angiogenesis Inhibitors 08-21-2008
421. 20080199423 Methods of Using Apo2l Receptor Agonists and Ink Cell Activators 08-21-2008